Inno-Gene SA operates within the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Inno-Gene SA with three other
miscellaneous service companies in Europe:
PCI Biotech Holding ASA
sales of 10.48 million Norwegian Kroner [US$1.31 million]
Faron Pharmaceuticals Oy
of the United Kingdom
(£946,543.82 [US$1.23 million]
Oxford Biodynamics PLC
based in the United Kingdom
(£1.09 million [US$1.42 million]
of which 100%
During the year ended December of 2016, sales at
Inno-Gene SA were 4.67 million Polish New Zlotys (US$1.27 million).
increase of 11.4%
versus 2015, when the company's sales were 4.19 million Polish New Zlotys.
This was the fifth consecutive year of sales increases at Inno-Gene SA
(and since 2011, sales have increased a total of 142%).